Cost effectiveness of rabies post exposure prophylaxis in the United States

被引：29
|
作者：
Dhankhar, Praveen [1 ]
Vaidya, Sagar A. [2 ]
Fishbien, Daniel B. [3 ]
Meltzer, Martin I. [1 ]
机构：
[1] Ctr Dis Control & Prevent, Div Emerging Infect & Surveillance Serv, Coordinating Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Mt Sinai Sch Med, Combined Internal Med Pediat Program, New York, NY USA
[3] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA 30333 USA
来源：
VACCINE | 2008年 / 26卷 / 33期
关键词：
rabies; vaccine; post exposure prophylaxis; cost per life saved; cost effectiveness; dogs; raccoons; United States;
D O I：
10.1016/j.vaccine.2008.05.048
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
There is growing concern in the United States about the excessive use of rabies post exposure prophylaxis (PEP) treatment. In this paper we have estimated the cost effectiveness of rabies PEP treatment under various scenarios of rabies transmission. When the risk of a patient getting rabies is deemed greater than 0.7%, then giving PEP will be cost saving (societal perspective). For lower risks of transmission, cost effectiveness estimates ranged from approximately $500,000 per life saved to $billions. The uncertainty caused by the wide range of cost effectiveness can only be resolved through analysis of data describing rabies transmission risk in a variety of scenarios. Published by Elsevier Ltd.
引用
收藏
页码：4251 / 4255
页数：5
相关论文
共 50 条
  • [31] Rabies post-exposure prophylaxis in the emergency department
    Lewis, Terese
    Baack, Krysta
    Gomez, Leigh
    Nichols, Heather
    Lemmons, Caitlin
    Zeger, Wesley
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2024, 78 : 202 - 205
  • [32] Just the facts: rabies post-exposure prophylaxis
    Omar Ahmad
    Maxwell Moor-Smith
    Paul Hasselback
    Canadian Journal of Emergency Medicine, 2021, 23 : 153 - 155
  • [33] Improving human rabies post-exposure prophylaxis
    Blumberg, Lucille
    Rupprecht, Charles E.
    LANCET INFECTIOUS DISEASES, 2019, 19 (12): : 1273 - 1274
  • [34] VARICELLA VACCINE AS POST-EXPOSURE PROPHYLAXIS - A COST-EFFECTIVENESS ANALYSIS
    Chui, K. S.
    Wu, H. L.
    You, J.
    VALUE IN HEALTH, 2013, 16 (07) : A357 - A357
  • [35] Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia
    Guinot, D.
    Ho, M. T.
    Poynten, I. M.
    McAllister, J.
    Pierce, A.
    Pell, C.
    Grulich, A. E.
    HIV MEDICINE, 2009, 10 (04) : 199 - 208
  • [36] Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States
    Leech, Ashley A.
    Burgess, James F.
    Sullivan, Meg
    Kuohung, Wendy
    Horny, Michal
    Drainoni, Mari-Lynn
    Christiansen, Cindy L.
    Linas, Benjamin P.
    AIDS, 2018, 32 (18) : 2787 - 2798
  • [37] Post-exposure influenza prophylaxis with oseltamivir - Cost effectiveness and cost utility in families in the UK
    Sander, B
    Hayden, FG
    Gyldmark, M
    Garrison, LP
    PHARMACOECONOMICS, 2006, 24 (04) : 373 - 386
  • [38] IMMUNE RESPONSE AND COST ANALYSIS OF INTRADERMAL RABIES VACCINATION FOR POST-EXPOSURE PROPHYLAXIS REGIMEN IN HUMAN
    Budayanti, N. S.
    Susilawathi, N. M.
    Darwinata, A. E.
    Dwija, I. B. P.
    Fatmawati, N. D.
    Wirasandhi, K.
    Subrata, K.
    Susilarini, N. K.
    Wignall, F. S.
    Sudewi, A. A. R.
    Mahardika, G. N. K.
    BALI MEDICAL JOURNAL, 2014, 3 (01) : 18 - 24
  • [39] Fatal rabies despite appropriate post-exposure prophylaxis
    John, BM
    Patnaik, SK
    INDIAN PEDIATRICS, 2005, 42 (08) : 839 - 840
  • [40] Recombinant monoclonal antibodies for rabies post-exposure prophylaxis
    E. N. Ilina
    M. V. Larina
    T. K. Aliev
    D. A. Dolgikh
    M. P. Kirpichnikov
    Biochemistry (Moscow), 2018, 83 : 1 - 12
12345